Partner Content Partner Content Career opportunities for graduates in the pharmaceutical ind... Career opportunities for graduates in healthcare
Events Partner Content J+D Forecasting bring their Face-to-Face Pharma training to ... Face-to-Face Pharma Forecasting Training in Boston
Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
Events Partner Content 13th Annual Industry Leading Cold Chain Distribution Confere... 13th Cold Chain Distribution Conference 2018
Partner Content Partner Content Pharmaceutical Microbiology USA Event takes place in less th... SMi Pharma Micro West Coast USA
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
